Folic Acid Inhibits Amyloid β-Peptide Production through Modulating DNA Methyltransferase Activity in N2a-APP Cells

Int J Mol Sci. 2015 Oct 20;16(10):25002-13. doi: 10.3390/ijms161025002.

Abstract

Alzheimer's disease (AD) is a common neurodegenerative disease resulting in progressive dementia, and is a principal cause of dementia among older adults. Folate acts through one-carbon metabolism to support the methylation of multiple substrates. We hypothesized that folic acid supplementation modulates DNA methyltransferase (DNMT) activity and may alter amyloid β-peptide (Aβ) production in AD. Mouse Neuro-2a cells expressing human APP695 were incubated with folic acid (2.8-40 μmol/L), and with or without zebularine (the DNMT inhibitor). DNMT activity, cell viability, Aβ and DNMTs expression were then examined. The results showed that folic acid stimulated DNMT gene and protein expression, and DNMT activity. Furthermore, folic acid decreased Aβ protein production, whereas inhibition of DNMT activity by zebularine increased Aβ production. The results indicate that folic acid induces methylation potential-dependent DNMT enzymes, thereby attenuating Aβ production.

Keywords: Alzheimer’s disease; DNA methyltransferases; amyloid β-peptide; folic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / enzymology
  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Cell Line, Tumor
  • DNA Methylation / drug effects
  • DNA Modification Methylases / metabolism
  • Enzyme Activation / drug effects
  • Folic Acid / pharmacology
  • Folic Acid / therapeutic use*
  • Humans
  • Mice

Substances

  • Amyloid beta-Peptides
  • Folic Acid
  • DNA Modification Methylases